USA flag logo/image

An Official Website of the United States Government

Effect of Protein on 5-Fluorouracil and Cyclophosphamide

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
21974
Program Year/Program:
1993 / SBIR
Agency Tracking Number:
21974
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
TECHNICAL RESEARCH ASSOC., INC.
P.O. Box 15278 Honolulu, HI 96830
View profile »
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1993
Title: Effect of Protein on 5-Fluorouracil and Cyclophosphamide
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

Feeding rats a semipurified diet containing casein as a protein source results in severe gastrointestinal (GI) toxicity when the chemotherapeutic drug methotrexate (MTX) is given. However, when soy concentrate protein is used in place of casein, rats are completely protected from toxicity. The purpose is to determine if soy concentrate protein is protective against cyclophosphamide (CY) and 5-fluorouracil (5-FU) toxicity in rats. 5-fluorouracil is a chemotherapeutic drug that causes severe side effects to the GI tract because of its effect on cell division. If soy concentrate proves to be protective in toxicity associated with chemotherapy, it could easily be incorporated into an enteral product and be tested in cancer patients to boost their nutrient intake. This soy product would help to maintain patients' adequate nutrition and, therefore, their nutritional status which has been shown to increase tolerance to chemotherapy. Further, if toxic side effects were minimized, it may be possible to increase doses of drugs and more effectively kill tumor cells.

Principal Investigator:

Nathalie Chevreau
8014854991

Business Contact:

Small Business Information at Submission:

Technical Research Associates,
2257 South 1100 East Salt Lake City, UT 84106

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No